2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in

Paperboy Ventures

Status
ACTIVE
Global HQ
Washington D.C., USA
Countries of investment
  • USA
Investment stages
  • Growth
  • IPO
Industries
  • Life Sciences
  • Biotech
  • FoodTech
  • D2C
  • Consumer Products
  • Science & Tech
About
Paperboy Ventures is a specialized venture firm based in Washington D.C., founded in 2000. They are known for maintaining a highly concentrated portfolio, allowing for deep involvement in their investments. A notable success includes their early and sustained backing of Corcept Therapeutics, showcasing their ability to navigate complex regulatory and public market environments in the US biotech space.
Min check size
$5M
Max check size
$25M
Fund size
NPS

Investment Thesis

Paperboy Ventures invests in life sciences and deep tech companies entering growth or IPO phases after significant technical validation.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Paperboy Ventures is led by a team with over 50 years of combined experience in venture capital and executive leadership. Chairman Allen Andersson brings decades of expertise in high-tech entrepreneurship and public market transitions, supported by a team of seasoned biotech operators who specialize in navigating the FDA regulatory landscape and complex scientific intellectual property.

Paperboy Ventures Contacts Information

Primary contact

Team

Allen Andersson - Chairman

Christian Vandendriessche - Managing Director

Portfolio

Corcept Therapeutics

LifeLock

23andMe

Genomic Health

Relypsa

Xenon Pharmaceuticals

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp